ASCO Lung Cancer Highlights, Part 11: Nintedanib with Second Line Chemotherapy for Advanced NSCLC (audio)
- Author
- cancerGRACE - H. Jack West, MD
- Published
- Mon 26 Aug 2013
- Episode Link
- http://cancergrace.libsyn.com/asco-lung-cancer-highlights-part-11-nindetanib-with-second-line-chemotherapy-for-advanced-nsclc-audio
Dr. Edward Garon, David Geffen School of Medicine at UCLA, discusses results in a trial that demonstrated a significant survival benefit with nintedanib combined with second line docetaxel in advanced lung adenocarcinoma.
